Last updated: August 18, 2026

Examiner: KIRWIN, STEFANIE JOHANNA

Tech Center 1600 • Art Units: 1677 1684

This examiner grants 15% of resolved cases

Performance Statistics

15.4%

Allow Rate

-44.6% vs TC avg

Total Applications

+35.3%

Interview Lift

1595

Avg Prosecution Days

Based on 39 resolved cases, 2023–2026

10.9%

§101 Eligibility

10.9%

§102 Novelty

45.7%

§103 Obviousness

27.6%

§112 Clarity

App #	Title	Status	Assignee
17284586	IMMUNOASSAY FOR MEASURING C-PEPTIDE	Non-Final OA	Roche Diabetes Care Inc.
17532969	COMPOSITIONS AND METHODS FOR RAPID COVID-19 DETECTION	Non-Final OA	ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
17386733	BIOMARKERS FOR CONGENITAL VASCULAR MALFORMATIONS	Non-Final OA	University of South Carolina
15965748	METHODS AND SYSTEMS FOR ANALYZING TISSUE QUALITY USING MID-INFRARED SPECTROSCOPY	Non-Final OA	Roche Diagnostics Operations, Inc.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.